LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Home・Stock List・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Closed

SectorHealthcare

22.58 -3.75

Buy Sell

Overview

Share price change

24h

Current

Min

22.34

Max

22.67

Key metrics
By Trading Economics
Income	-1.8M -21M
Sales	4.1M 83M
Profit margin	-25.695
Employees	756
EBITDA	4.8M -19M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+81.97% upside

Dividends
By Dow Jones
Next Earnings	23 Apr 2026

Market Stats
By TradingEconomics
Market Cap	-391M 1.5B
Previous open	26.33
Previous close	22.58

News Sentiment

By Acuity

100%

332 / 352 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

52.655 / 56.31 Support & Resistance

PROCEPT BioRobotics Corp Chart

Past performance is not a reliable indicator of future results.

Related News

27 Feb 2026, 23:53 UTC

Hot Stocks

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 Feb 2026, 22:23 UTC

Acquisitions, Mergers, Takeovers

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28 Feb 2026, 21:36 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 Feb 2026, 15:20 UTC

Earnings

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28 Feb 2026, 14:43 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 Feb 2026, 14:38 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28 Feb 2026, 13:47 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 Feb 2026, 13:44 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28 Feb 2026, 13:14 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 Feb 2026, 02:32 UTC

Earnings

Acquisitions, Mergers, Takeovers

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28 Feb 2026, 02:00 UTC

Acquisitions, Mergers, Takeovers

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28 Feb 2026, 02:00 UTC

Acquisitions, Mergers, Takeovers

Six Months, 9 Offers and $81 Billion. How -2-

28 Feb 2026, 00:01 UTC

Acquisitions, Mergers, Takeovers

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27 Feb 2026, 23:46 UTC

Acquisitions, Mergers, Takeovers

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 Feb 2026, 23:33 UTC

Acquisitions, Mergers, Takeovers

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 Feb 2026, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

27 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 Feb 2026, 21:30 UTC

Earnings

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 Feb 2026, 21:30 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 Feb 2026, 21:20 UTC

Acquisitions, Mergers, Takeovers

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 Feb 2026, 21:17 UTC

Earnings

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 Feb 2026, 21:10 UTC

Acquisitions, Mergers, Takeovers

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 Feb 2026, 21:09 UTC

Acquisitions, Mergers, Takeovers

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 Feb 2026, 21:00 UTC

Earnings

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 Feb 2026, 20:31 UTC

Acquisitions, Mergers, Takeovers

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 Feb 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27 Feb 2026, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27 Feb 2026, 20:12 UTC

Market Talk

Nike Seen With Further Challenges in China -- Market Talk

27 Feb 2026, 19:44 UTC

Market Talk

Gold Caps Historic Month -- Market Talk

27 Feb 2026, 19:39 UTC

Earnings

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

81.97% upside

12 Months Forecast

Average 41.29 USD 81.97%

High 62 USD

Low 20 USD

Based on 10 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to PROCEPT BioRobotics Corp - Dist in the past 3 months.

Technical Score

By Trading Central

52.655 / 56.31Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.